GRI-004

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameGRI-004

Drug Alias Namenatural killer cell type II modulator (GRI Bio)sulfatide mimetics (Glycoregimmune)sulfatide mimetics (GRI Bio)natural killer cell type II modulator (Glycoregimmune)GRI-004

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionImmunomodulatorsNatural killer T-lymphocyte stimulants

TargetsUpdating

Therapy Area/IndicationsAutoimmune DiseasesReperfusion InjuryLiver Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGri Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGri Bio Inc

Active IndicationsN/A

Inactive IndicationsAutoimmune DiseasesReperfusion InjuryLiver Diseases

Other Information

ATC CodeN/A